Neurocrine Biosciences | Прибыль До Налогообложения


Pre Tax Profit Изменить
Abbvie ABBV:US $ 6567M 197M
Acadia Pharmaceuticals ACAD:US $ -112.57M 69.67M
Agios Pharmaceuticals AGIO:US $ -94.77M 3.81M
Alnylam Pharmaceuticals ALNY:US $ -239.36M 20.95M
Amgen AMGN:US $ 2727M 56M
Biogen BIIB:US $ 903.4M 316.6M
Biomarin Pharmaceutical BMRN:US $ 26.19M 92.76M
Cytokinetics CYTK:US $ -86.75M 56.18M
Dynavax Technologies DVAX:US $ 32.86M 67.73M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.44M
Exelixis EXEL:US $ 85.23M 32.79M
Halozyme Therapeutics HALO:US $ 81.63M 20.43M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Intra Cellular Therapies ITCI:US $ -72.11M 13.62M
IONIS PHARMACEUT IONS:US $ -64M 289M
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Neurocrine Biosciences NBIX:US $ 21.4M 35.2M
Pfizer PFE:US $ 11328M 4083M
Prothena PRTA:US $ -37.96M 4.86M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M
Repligen RGEN:US $ 66.75M 10.48M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.74M
Sarepta Therapeutics SRPT:US $ -104.15M 17.74M
Teva Pharmaceutical TEVA:IT -971000000 796M
Ultragenyx Pharmaceutical RARE:US $ -151.76M 29.32M
Xoma XOMA:US $ -2.28M 32.22M
YTE INCY:US $ 172.84M 1.75M



Neurocrine Biosciences Прибыль До Налогообложения - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Jun 2022.